References
- ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological profile for arsenic. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry. Atlanta, GA: 559 p. https://www.atsdr.cdc.gov/toxprofiles/tp2.pdf.
- ATSDR (Agency for Toxic Substances and Disease Registry). 2016. Addendum to the toxicological profile for arsenic. Agency for Toxic Substances and Disease Registry, Division of Toxicology and Human Health Sciences. Atlanta, GA: 189 p. http://www.atsdr.cdc.gov/toxprofiles/Arsenic_addendum.pdf.
- Bradham, K. D., K. G. Scheckel, C. M. Nelson, P. E. Seales, G. E. Lee, M. F. Hughes, B. W. Miller, A. Yeow, T. Gilmore, S. Harper, et al. 2011. Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils. Environ. Health. Perspect. 119:1629–34. doi:https://doi.org/10.1289/ehp.1003352.
- Bradham, K. D., G. L. Diamond, K. G. Scheckel, M. F. Hughes, S. W. Casteel, B. W. Miller, J. M. Klotzbach, W. C. Thayer, and D. J. Thomas. 2013. Mouse assay for determination of arsenic bioavailability in contaminated soils. J. Toxicol. Environ. Health A 76:815–26. doi:https://doi.org/10.1080/15287394.2013.821395.
- Bradham, K., G. Diamond, A. Juhasz, C. Nelson, and D. Thomas. 2018a. Comparison of mouse and swine bioassays for determination of soil arsenic relative bioavailability. Appl. Geochem. 88:221–25. doi:https://doi.org/10.1016/j.apgeochem.2017.05.016.
- Bradham, K. D., G. L. Diamond, M. Burgess, A. Juhasz, J. M. Klotzbach, M. Maddaloni, C. Nelson, K. Scheckel, S. M. Serda, M. Stifelman, et al. 2018b. In vivo and in vitro methods for evaluating soil arsenic bioavailability: Relevant to human health risk assessment. J. Toxicol. Environ. Health Part B. 21:83–114. doi:https://doi.org/10.1080/10937404.2018.1440902.
- Bradham, K. D., C. Herde, P. Herde, A. Juhasz, K. Herbin-Davis, B. Elek, A. Farthing, G. L. Diamond, and D. J. Thomas. 2020. Intra- and inter-laboratory evaluation of an assay of soil arsenic relative bioavailability in mice. J. Agric. Food. Chem. 68:2615–22. doi:https://doi.org/10.1021/acs.jafc.9b06537.
- Brattin, W., and S. Casteel. 2013. Measurement of arsenic relative bioavailability in swine. J. Toxicol. Environ. Health Part A 76:449–57. doi:https://doi.org/10.1080/15287394.2013.771562.
- Buchet, J. P., R. Lauwerys, and H. Roels. 1981a. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int. Arch. Occup. Environ. Health 48:111–18. doi:https://doi.org/10.1007/BF00378431.
- Buchet, J. P., R. Lauwerys, and H. Roels. 1981b. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48:71–79. doi:https://doi.org/10.1007/BF00405933.
- Crecelius, E. A. 1977. Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19:147–50. doi:https://doi.org/10.1289/ehp.7719147.
- Csanaky, I., and Z. Gregus. 2002. Species variation in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 131:335–65. doi:https://doi.org/10.1016/S1532-0456(02)00018-2.
- Davis, A., M. V. Ruby, M. Bloom, R. Schoof, G. Freeman, and P. D. Bergstrom. 1996. Mineralogic constraints on the bioavailability of arsenic in smelter-impacted soils. Environ. Sci. Technol. 30:392–99. doi:https://doi.org/10.1021/es9407857.
- Diamond, G. L., K. D. Bradham, W. J. Brattin, M. Burgess, S. Griffin, C. A. Hawkins, A. L. Juhasz, J. M. Klotzbach, C. Nelson, Y. W. Lowney, et al. 2016. Predicting oral relative bioavailability of arsenic in soil from in vitro bioaccessibility. J. Toxicol. Environ. Health A 79:165–73. doi:https://doi.org/10.1080/15287394.2015.1134038.
- Drobna, Z., H. Narenmandurs, K. M. Kubachka, B. C. Edwards, K. Herbin-Davis, M. Styblo, X. C. Le, J. T. Creed, N. Maeda, M. G. Hughes, et al. 2009. Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22:1713–20. doi:https://doi.org/10.1021/tx900179r.
- Ellacott, K. L., G. J. Morton, S. C. Woods, P. Tso, and M. W. Schwartz. 2010. Assessment of feeding behavior in laboratory mice. Cell Metab. 12:10–17. doi:https://doi.org/10.1016/j.cmet.2010.06.001.
- Freeman, G. B., J. D. Johnson, J. M. Killinger, S. C. Liao, A. O. Davis, M. V. Ruby, R. L. Chaney, S. C. Lovre, and P. D. Bergstrom. 1993. Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits. Fundam. Appl. Toxicol. 21:83–88. doi:https://doi.org/10.1006/faat.1993.1075.
- Freeman, G. B., R. A. Schoof, M. V. Ruby, A. O. Davis, J. A. Dill, S. C. Liao, C. A. Lapin, and P. D. Bergstrom. 1995. Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys. Fundam. Appl. Toxicol. 28:215–22. doi:https://doi.org/10.1006/faat.1995.1162.
- Hughes, M. F., E. M. Kenyon, B. C. Edwards, C. T. Mitchell, L. M. Del Razo, and D. J. Thomas. 2003. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol. Appl. Pharmacol. 191:202–10. doi:https://doi.org/10.1016/S0041-008X(03)00249-7.
- Hughes, M. F., B. C. Edwards, K. M. Herbin-Davis, J. Saunders, M. Styblo, and D. J. Thomas. 2010. Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol. Appl. Pharmacol. 249:217–23. doi:https://doi.org/10.1016/j.taap.2010.09.017.
- Hughes, M. F., B. D. Beck, Y. Chen, A. S. Lewis, and D. J. Thomas. 2011. Arsenic exposure and toxicology: A historical perspective. Toxicol. Sci. 123:305–32. doi:https://doi.org/10.1093/toxsci/kfr184.
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2012. IARC monographs on the evaluation of carcinogenic risks to humans. No. 100C (Arsenic, Metals, Fibres and Dusts). Lyon: International Agency for Research on Cancer. 2012.
- Juhasz, A. L., E. Smith, J. Weber, R. Naidu, M. Rees, A. Rofe, T. Kuchel, L. Sansom, and R. Naidu. 2006. In vivo assessment of arsenic bioavailability in rice and its significance for human health assessment. Environ. Health Perspect. 114:1826–31. doi:https://doi.org/10.1289/ehp.9322.
- Juhasz, A. L., E. Smith, J. Weber, R. Naidu, M. Rees, A. Rofe, T. Kuchel, L. Sansom, and R. Naidu. 2007. Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soils. Chemosphere 69:961–66. doi:https://doi.org/10.1016/j.chemosphere.2007.05.018.
- Kenyon, E. M., M. F. Hughes, B. M. Adair, J. H. Highfill, E. A. Crecelius, H. J. Clewell, and J. W. Yager. 2008. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol. Appl. Pharmacol. 232:448–445. doi:https://doi.org/10.1016/j.taap.2008.07.018.
- Kumana, C. R., W. Y. Au, N. S. L. Lee, M. Kou, R. W. M. Mak, C. W. Lam, and Y. L. Kwong. 2002. Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies. Eur. J. Pharmacol. 58:521–26.
- Li, J., C. Li, H.-J. Sun, A. L. Juhasz, J. Luo, H.-B. Li, and L. Q. Ma. 2016. Arsenic relative bioavailability in contaminated soils: Comparison of animal models, dosing schemes, and biological endpoints. Environ. Sci. Technol. 50:453–61. doi:https://doi.org/10.1021/acs.est.5b04552.
- Li, H.-B., H. Ning, S.-W. Li, J. Li, R.-Y. Xue, M.-Y. Li, M.-Y. Wang, J.-H. Liang, A. L. Juhasz, and L. Q. Ma. 2021. An interlaboratory evaluation of the variability in arsenic and lead relative bioavailability when assessed using a mouse assay. J. Toxicol. Environ. Health Part A 84:593–607. doi:https://doi.org/10.1080/15287394.2021.1919947.
- Mappes, R. 1977. Experiments on excretion of arsenic in urine. Int. J. Occup. Environ. Health 40:267–72. doi:https://doi.org/10.1007/BF00381415.
- Murko, M., B. Elek, M. Styblo, D. J. Thomas, and K. A. Francesconi. 2018. Dose and diet – Sources of arsenic intake in mouse in utero exposure scenarios. Chem. Res. Toxicol. 31:156–64. doi:https://doi.org/10.1021/acs.chemrestox.7b00309.
- Odezulu, N. G., Y. W. Lowney, K. M. Portier, M. Kozuch, A. R. Bacon, S. M. Roberts, and L. D. Suchal. 2022. Effect of sol particle and extraction method on the oral bioaccessibility of arsenic. J. Toxicol. Environ. Health Part A 85:538–52. doi:https://doi.org/10.1080/15287394.2022.2048935.
- Reeves, P. G. P. G., F. H. Nielsen, and G. C. Fahey. 1993. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939–51. doi:https://doi.org/10.1093/jn/123.11.1939.
- Rehman, M. U., R. Khan, A. Khan, W. Qamar, A. Arafah, P. Ahmad, P. Ahmad, P. Ahmad, P. Ahmad, and P. Ahmad. 2021. Fate of arsenic in living systems: Implications for sustainable and safe food chains. J. Hazard. Mater. 417:126050. doi:https://doi.org/10.1016/j.jhazmat.2021.126050.
- Roberts, S. M., W. R. Weimar, J. R. Vinson, J. W. Munson, and R. J. Bergeron. 2002. Measurement of arsenic bioavailability in soil using a primate model. Toxicol. Sci. 67:303–10. doi:https://doi.org/10.1093/toxsci/67.2.303.
- Roberts, S. M., J. W. Munson, Y. W. Lowney, and M. V. Ruby. 2007. Relative oral bioavailability of arsenic from contaminated soils measured in the Cynomolgus monkey. Toxicol. Sci. 95:281–88. doi:https://doi.org/10.1093/toxsci/kfl117.
- Stanek, E. J., E. J. Calabrese, R. M. Barnes, J. M. C. Danku, Y. Zhou, P. T. Kostecki, and E. Zillioux. 2010. Bioavailability of arsenic in soil: Pilot study results and design considerations. Human. Exp. Toxicol. 29:945–60. doi:https://doi.org/10.1177/0960327110363860.
- Tam, G. K. H., S. M. Charbonneau, F. Bryce, C. Pomroy, and E. Sandi. 1979. Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 50:319–22. doi:https://doi.org/10.1016/0041-008X(79)90157-1.
- Thomas, D. J., and K. Bradham. 2016. Role of complex organic arsenicals in food in aggregate exposure to arsenic. J. Environ. Sci. 49:86–96. ( China). doi:https://doi.org/10.1016/j.jes.2016.06.005.
- U.S. Environmental Protection Agency. 2012. Compilation and review of data on relative bioavailability of arsenic in soil. Washington, DC: U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response. OSWER 9200.1–113. https://www.epa.gov/superfund/soil-bioavailability-superfund-sites-guidance.
- U.S. Environmental Protection Agency. 2020. Guidance for sample collection for in vitro bioaccessibility assay for arsenic and lead in soil and applications of relative bioavailability data in human health risk assessment. Washington, DC: U.S. Environmental Protection Agency, Office of Solid Waste and Emergency Response. OSWER 9200.3–100a. https://www.epa.gov/superfund/soil-bioavailability-superfund-sites-guidance.
- U.S. Environmental Protection Agency. 2021. Arsenic, inorganic (CASRN 7440-38-2). Integrated Risk Information System (IRIS). Accessed July 19 2021. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0278_summary.pdf#nameddest=rfd.
- WHO (World Health Organization). 2011. Arsenic in drinking water. Background document for development of WHO guidelines for drinking-water quality. Geneva, Switzerland: World Health Organization. WHO/SDE/WSH03.04/75.rev1.
- Wolle, M. M., S. Stadig, and S. D. Conklin. 2019. Market basket survey of arsenic species in the top ten most consumed seafoods in the United States. J. Agric. Food Chem. 67:8253–67. doi:https://doi.org/10.1021/acs.jafc.9b02314.
- Zheng, Y., J. Wu, J. C. Ng, G. Wang, and W. Lian. 2002. The absorption and excretion of fluoride and arsenic in humans. Toxicol. Lett. 133:77–82. doi:https://doi.org/10.1016/S0378-4274(02)00082-6.